Physical Therapy for Bladder Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if meeting with a physical therapist before bladder removal surgery can reduce complications and improve recovery for bladder cancer patients. Participants will receive a customized exercise plan to follow before surgery. The goal is to assess whether this approach aids recovery time, reduces hospital stays, and lowers the chance of readmission. Candidates for this trial include those diagnosed with bladder cancer and scheduled for bladder removal surgery. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to important findings.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this physical therapy consultation is safe for bladder cancer patients?
Research has shown that exercise programs before surgery can be safe for bladder cancer patients. These programs can help reduce complications and improve the quality of life for those undergoing bladder surgery. Studies have demonstrated that exercise before surgery is safe and manageable for patients.
In one study, patients participated in a 4-week exercise program before their surgery. The program did not cause major issues, suggesting it is safe. Another review found that prehabilitation, or exercise before surgery, benefited bladder cancer patients, with most studies showing positive outcomes.
Overall, current research supports that physical therapy and exercise are safe for bladder cancer patients preparing for surgery.12345Why are researchers excited about this trial?
Unlike the standard treatments for bladder cancer, which often involve surgery, chemotherapy, or immunotherapy, this new approach focuses on a physical therapy regimen tailored to each patient. Researchers are excited because this method is designed to enhance patients' physical condition before surgery, potentially improving recovery times and outcomes. By offering a personalized exercise program, it addresses the individual needs of patients, which is a unique angle not typically explored in traditional bladder cancer treatments.
What evidence suggests that this physical therapy is effective for bladder cancer?
Research shows that exercise programs can greatly benefit bladder cancer patients undergoing surgery. In this trial, participants will receive a personalized exercise program after a Physical Therapy assessment, prior to their surgery. Studies have found that exercise can reduce the risk of complications and enhance both physical and emotional health. Specifically, 71% of the studies reviewed found that exercising before surgery benefited bladder cancer patients. This pre-surgery exercise, known as prehabilitation, helps patients feel more involved in their care and improves their overall well-being. Overall, exercising before surgery appears to lead to better outcomes for bladder cancer patients.13456
Who Is on the Research Team?
Sasha E Knowlton, MD
Principal Investigator
Lineberger Comprehensive Cancer Center, The University of North Carolina Chapel Hill
Are You a Good Fit for This Trial?
This trial is for adults over 18 years old who have been diagnosed with bladder cancer and are scheduled to undergo a radical cystectomy. It's not open to those without a history of bladder cancer or who haven't had the surgery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-cystectomy Physical Therapy
Participants receive a physical therapy consultation and a personally tailored exercise program before surgery
Post-cystectomy Follow-up
Participants are monitored for post-operative complications, morbidity, and readmission rates
What Are the Treatments Tested in This Trial?
Interventions
- Physical Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
UNC Lineberger Comprehensive Cancer Center
Lead Sponsor